Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats. (Q48627086)

13 February 2018

title

Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats. (English)

1 reference

13 February 2018

0 references

1 reference

6

1 reference

13 February 2018

author name string

Guyot MC

1

1 reference

13 February 2018

Palfi S

2

1 reference

13 February 2018

Stutzmann JM

3

1 reference

13 February 2018

Mazière M

4

1 reference

13 February 2018

Hantraye P

5

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 November 1997

1 reference

13 February 2018

published in

Neuroscience

1 reference

13 February 2018

volume

81

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

141-149

1 reference

13 February 2018

Mammalian succinate dehydrogenase

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Aging, energy, and oxidative stress in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on D-[3H]aspartate release from cultured cerebellar granule cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Systemic 3-nitropropionic acid: long-term effects on locomotor behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Riluzole anesthesia: use-dependent block of presynaptic glutamate fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Effect of riluzole on quinolinate-induced neuronal damage in rats: comparison with blockers of glutamatergic neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Riluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Growth of the rat somatic sensory cortex and its constituent parts during postnatal development

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

Towards an understanding of the role of glutamate in neurodegenerative disorders: energy metabolism and neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900192-9

7 January 2021

10.1016/S0306-4522(97)00192-9

Identifiers

DOI

1 reference

13 February 2018

release_nbr6zwfefrctrjpf6vnarvjhx4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nbr6zwfefrctrjpf6vnarvjhx4

24 November 2022

mapped directly with Wikidata item

1 reference

13 February 2018